A new study published in the journal of BMC Gastroenterology showed that dementia risk was higher in patients with metabolic ...

Pregnant women with MASLD have over three times the risk of preterm birth, according to Swedish registry data. This risk ...

DelveInsight's analysis forecasts liver fibrosis market growth due to the introduction of emerging therapies, expecting an increase in market size during the study period (2020–2034). This anticipated ...

Pregnant women with metabolic dysfunction-associated steatotic liver disease (MASLD) have an increased risk of giving birth ...

Discover a study presented at EASL 2025 that found that timely public health policies can reduce the global burden of MASLD.

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

Menopause at an earlier age increases risk of fatty liver disease and metabolic disorders - ...

Early menopause before age 50 significantly increases the risk of fatty liver disease and metabolic disorders, according to ...

A pioneering research study published today in Cell Metabolism details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works ...

Researchers at the University of Oklahoma report a hormone, FGF21, may reverse fatty liver disease by signaling the brain.